MFG
IRWD icon

Magnus Financial Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Magnus Financial Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.8K Buy
+18,005
New +$69.4K 0.01% 386

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Magnus Financial Group's IRWD Position: Q2 2026 in Review

Magnus Financial Group opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 18,005 shares worth $75.8K. The stake represents 0.01% of the portfolio and ranks #386 among its holdings.

212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Magnus Financial Group held 18,005 shares of Ironwood Pharmaceuticals worth $75.8K as of Q2 2026.
  • Ironwood Pharmaceuticals was a new Magnus Financial Group position in Q2 2026.
  • Ironwood Pharmaceuticals made up 0.01% of Magnus Financial Group's portfolio in Q2 2026, its #386 holding.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.